
Related topics: Financial & Industry
DSM has added two new markets to the list for which it has expressed approval for its acrylamide-busting asparaginase enzyme, as it progresses towards global roll out.
Since its enzyme, called Preventase, was launched, the company has been working on approvals so that it can be applied to baked good worldwide. It is understood to dramatically reduce the formation of cancer-causing acrylamide during the Maillard reaction.
Preventase is also cleared for use in the US, Australia, New Zealand, France, Switzerland, Denmark, Mexico and Russia. In the EU, with the exception of France and The Netherlands, enzymes as processing aids do not currently need pre-market approval.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions
© 2012 - William Reed Business Media SAS - All rights reserved. ![]()